Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08KNP
|
||||
Former ID |
DIB020497
|
||||
Drug Name |
N-benzyl brucine
|
||||
Synonyms |
BNO
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [540280] | ||
Structure |
Download2D MOL |
||||
Formula |
C30H33N2O4+
|
||||
InChI |
InChI=1S/C30H33N2O4/c1-34-23-13-21-22(14-24(23)35-2)31-27(33)15-25-28-20-12-26-30(21,29(28)31)9-10-32(26,17-19(20)8-11-36-25)16-18-6-4-3-5-7-18/h3-8,13-14,20,25-26,28-29H,9-12,15-17H2,1-2H3/q+1/t20-,25-,26-,28-,29-,30+,32?/m0/s1
|
||||
InChIKey |
XFMQETLKDRNYRE-QIBSSCBHSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Muscarinic receptor | Target Info | Modulator (allosteric modulator) | [534573] | |
Muscarinic acetylcholine receptor M3 | Target Info | Modulator (allosteric modulator) | [534573] | ||
KEGG Pathway | Calcium signaling pathway | ||||
cAMP signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
PI3K-Akt signaling pathway | |||||
Cholinergic synapse | |||||
Regulation of actin cytoskeletonhsa04020:Calcium signaling pathway | |||||
Regulation of actin cytoskeleton | |||||
Insulin secretion | |||||
Salivary secretion | |||||
Gastric acid secretion | |||||
Pancreatic secretion | |||||
PathWhiz Pathway | Muscle/Heart ContractionPW000565:Gastric Acid Production | ||||
WikiPathways | Monoamine GPCRs | ||||
Calcium Regulation in the Cardiac Cell | |||||
Regulation of Actin Cytoskeleton | |||||
GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
Secretion of Hydrochloric Acid in Parietal Cells | |||||
GPCR ligand binding | |||||
GPCR downstream signalingWP58:Monoamine GPCRs | |||||
Integration of energy metabolism | |||||
GPCR downstream signaling | |||||
GPCRs, Other | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.